Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enhanced Prophylaxis vs Standard in fURS
NCT04731090Completed
- Sponsor
- Egyptian Biomedical Research Network
- Start
- Aug 2018
- Primary completion
- Sep 2020
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms), sponsored by Egyptian Biomedical Research Network. Primary endpoint: Urinary tract infection at 30 days. Started Aug 2018; status: completed.
Beyond the preview
Go deeper on NCT04731090.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04731090.